Terms: = Endocrine gland cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Clinical Outcome
19 results:
1. Targeting homologous recombination deficiency in uterine leiomyosarcoma.
Dall G; Vandenberg CJ; Nesic K; Ratnayake G; Zhu W; Vissers JHA; Bedő J; Penington J; Wakefield MJ; Kee D; Carmagnac A; Lim R; Shield-Artin K; Milesi B; Lobley A; Kyran EL; O'Grady E; Tram J; Zhou W; Nugawela D; Stewart KP; Caldwell R; Papadopoulos L; Ng AP; Dobrovic A; Fox SB; McNally O; Power JD; Meniawy T; Tan TH; Collins IM; Klein O; Barnett S; Olesen I; Hamilton A; Hofmann O; Grimmond S; Papenfuss AT; Scott CL; Barker HE
J Exp Clin Cancer Res; 2023 May; 42(1):112. PubMed ID: 37143137
[TBL] [Abstract] [Full Text] [Related]
2. Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer.
Dietze R; Hammoud MK; Gómez-Serrano M; Unger A; Bieringer T; Finkernagel F; Sokol AM; Nist A; Stiewe T; Reinartz S; Ponath V; Preußer C; von Strandmann EP; Müller-Brüsselbach S; Graumann J; Müller R
Theranostics; 2021; 11(3):1377-1395. PubMed ID: 33391540
[TBL] [Abstract] [Full Text] [Related]
3. Histopathologic Features and clinical outcome of Anaplastic Thyroid Carcinoma with a minor Anaplastic Component.
Wong KS; Lorch JH; Alexander EK; Marqusee E; Cho NL; Nehs MA; Doherty GM; Barletta JA
Endocr Pathol; 2020 Sep; 31(3):283-290. PubMed ID: 32445173
[TBL] [Abstract] [Full Text] [Related]
4. CT-guided percutaneous biopsy of suspect pancreatic lesions: radiological and clinical outcome.
Gruber-Rouh T; Langenbach MC; Eichler K; Vogl TJ; Yel I; Beeres M
Clin Radiol; 2019 Nov; 74(11):899.e7-899.e12. PubMed ID: 31495545
[TBL] [Abstract] [Full Text] [Related]
5. External validation of the Japanese difficulty scoring system for minimally-invasive distal pancreatectomies.
Goh BKP; Kabir T; Koh YX; Teo JY; Lee SY; Kam JH; Cheow PC; Jeyaraj PR; Chow PKH; Ooi LLPJ; Chung AYF; Chan CY
Am J Surg; 2019 Nov; 218(5):967-971. PubMed ID: 30910129
[TBL] [Abstract] [Full Text] [Related]
6. Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage.
Hosmann A; Micko A; Frischer JM; Roetzer T; Vila G; Wolfsberger S; Knosp E
World Neurosurg; 2019 Jun; 126():e723-e730. PubMed ID: 30851467
[TBL] [Abstract] [Full Text] [Related]
7. SPARC gene variants predict clinical outcome in locally advanced and metastatic pancreatic cancer patients.
Arqueros C; Salazar J; Arranz MJ; Sebio A; Mora J; Sullivan I; Tobeña M; Martín-Richard M; Barnadas A; Baiget M; Páez D
Med Oncol; 2017 Aug; 34(8):136. PubMed ID: 28687963
[TBL] [Abstract] [Full Text] [Related]
8. Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders.
Frenk NE; Sebastianes F; Lerario AM; Fragoso MC; Mendonca BB; Menezes MR
Clinics (Sao Paulo); 2016 Oct; 71(10):600-605. PubMed ID: 27759849
[TBL] [Abstract] [Full Text] [Related]
9. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
Dettmer MS; Schmitt A; Steinert H; Capper D; Moch H; Komminoth P; Perren A
Endocr Relat Cancer; 2015 Jun; 22(3):419-29. PubMed ID: 25870252
[TBL] [Abstract] [Full Text] [Related]
10. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
[TBL] [Abstract] [Full Text] [Related]
11. In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response.
Vaisman F; Tala H; Grewal R; Tuttle RM
Thyroid; 2011 Dec; 21(12):1317-22. PubMed ID: 22136267
[TBL] [Abstract] [Full Text] [Related]
12. [Minimally invasive video-assisted thyroidectomy].
Mizrachi A; Hazan A; Sadov R; Feinmesser R
Harefuah; 2011 Jun; 150(6):512-4, 552. PubMed ID: 21800488
[TBL] [Abstract] [Full Text] [Related]
13. Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.
Ji JS; Han CW; Jang JW; Lee BI; Kim BW; Choi H; Kim JY; Kang YN; Kay CS; Choi IB
Radiat Oncol; 2010 Jun; 5():60. PubMed ID: 20584299
[TBL] [Abstract] [Full Text] [Related]
14. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
[TBL] [Abstract] [Full Text] [Related]
15. ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
Johnatty SE; Beesley J; Paul J; Fereday S; Spurdle AB; Webb PM; Byth K; Marsh S; McLeod H; ; Harnett PR; Brown R; DeFazio A; Chenevix-Trench G
Clin Cancer Res; 2008 Sep; 14(17):5594-601. PubMed ID: 18765553
[TBL] [Abstract] [Full Text] [Related]
16. Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer.
Hussain MM; Kotz H; Minasian L; Premkumar A; Sarosy G; Reed E; Zhai S; Steinberg SM; Raggio M; Oliver VK; Figg WD; Kohn EC
J Clin Oncol; 2003 Dec; 21(23):4356-63. PubMed ID: 14645425
[TBL] [Abstract] [Full Text] [Related]
17. Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up.
Ferrante L; Trillò G; Ramundo E; Celli P; Jaffrain-Rea ML; Salvati M; Esposito V; Roperto R; Osti MF; Minniti G
J Neurooncol; 2002 Nov; 60(2):185-91. PubMed ID: 12635667
[TBL] [Abstract] [Full Text] [Related]
18. outcomes analysis in patients undergoing laparoscopic adrenalectomy for hormonally active adrenal tumors.
Brunt LM; Moley JF; Doherty GM; Lairmore TC; DeBenedetti MK; Quasebarth MA
Surgery; 2001 Oct; 130(4):629-34; discussion 634-5. PubMed ID: 11602893
[TBL] [Abstract] [Full Text] [Related]
19. Survival, response and immune effects in a prospectively randomized study of dose strategy for alpha-N1 interferon.
Silver HK; Connors JM; Kong S; Karim KA; Spinelli JJ
Br J Cancer; 1988 Dec; 58(6):783-7. PubMed ID: 2975951
[TBL] [Abstract] [Full Text] [Related]
